ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
125.970,46
-0,13%
S&P 500
5.994,57
-0,76%
US Dollar vs BRL
5,808
0,01%
Bitcoin
99.431,33
-1,96%
Brent Oil
74,975
-0,51%
As Melhores Corretoras Online
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Alcon Inc (ALC)

  7. Alcon Inc (ALC) Notícias

ALC

Alcon (ALC)

Alcon Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:ALC
DataHoraFonteTítuloCódigoCompanhia
31/12/202418:30Business WireAlcon to Present at 2025 Annual J.P. Morgan Healthcare ConferenceNYSE:ALCAlcon Inc
12/11/202414:21Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:ALCAlcon Inc
12/11/202414:09Business WireAlcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash GenerationNYSE:ALCAlcon Inc
07/11/202403:00Business WireAlcon Debuts Groundbreaking PRECISION7, a One-Week Replacement Contact Lens to Start and End Every Week FreshNYSE:ALCAlcon Inc
04/11/202409:00Business WireAlgoma Central Corporation Reports Financial Results for the 2024 Third QuarterNYSE:ALCAlcon Inc
27/10/202422:00Business WireAlcon Singapore Elevates Associate Experience with Inspiring Engagement ProgramsNYSE:ALCAlcon Inc
15/10/202410:03Business WireAlcon Innovations on Display at AAO 2024 Demonstrate Efficiency and PerformanceNYSE:ALCAlcon Inc
12/09/202418:34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ALCAlcon Inc
20/08/202417:30Business WireAlcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact LensesNYSE:ALCAlcon Inc
02/08/202408:00Business WireAlgoma Central Corporation Reports Financial Results for the 2024 Second QuarterNYSE:ALCAlcon Inc
24/06/202402:00Business WireAlcon’s Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) ClearanceNYSE:ALCAlcon Inc
29/05/202418:09Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:ALCAlcon Inc
13/05/202417:30Business WireAlcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular HealthNYSE:ALCAlcon Inc
08/05/202417:30Business WireAlcon Announces Results of 2024 Annual General MeetingNYSE:ALCAlcon Inc
01/05/202410:45Business WireAlgoma Central Corporation Reports Financial Results for the 2024 First QuarterNYSE:ALCAlcon Inc
07/04/202418:59Business WireAlcon Publishes Agenda for 2024 Annual General MeetingNYSE:ALCAlcon Inc
12/03/202405:30Business WireAlcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in IndiaNYSE:ALCAlcon Inc
06/03/202411:55Business WireVivity, the World’s Leading EDOF IOL, Reaches One Million MilestoneNYSE:ALCAlcon Inc
06/03/202411:55Business WireVivity, la LIO à profondeur focale accrue première au monde, atteint un million d’implantsNYSE:ALCAlcon Inc
27/02/202418:30Business WireAlcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023NYSE:ALCAlcon Inc
26/02/202409:00Business WireAlgoma Central Corporation Reports Financial Results for Fiscal 2023NYSE:ALCAlcon Inc
12/02/202418:22Business WireAlgoma Central Corporation to Issue Fiscal 2023 Financial Results on February 26, 2024NYSE:ALCAlcon Inc
01/02/202415:04Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:ALCAlcon Inc
01/02/202411:02Business WireAlcon Canada lance les lentilles cornéennes TOTAL30 Multifocal pour les patients porteurs de lentilles réutilisables atteints de presbytieNYSE:ALCAlcon Inc
18/01/202410:54Business WireAlgoma Central Corporation continues to grow product tanker business with the acquisition of two additional vesselsNYSE:ALCAlcon Inc
10/01/202406:12Dow Jones NewsAlcon Shares Rise After Dry-Eye Care Drug Shows Promising ResultsNYSE:ALCAlcon Inc
09/01/202419:20Dow Jones NewsAlcon Reports Results for Dry-Eye-Treatment TrialsNYSE:ALCAlcon Inc
09/01/202418:30Business WireAlcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry EyeNYSE:ALCAlcon Inc
05/01/202410:00GlobeNewswire Inc.Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial ArrangementsNYSE:ALCAlcon Inc
27/12/202311:01Business WireAlcon to Present at 2024 Annual J.P. Morgan Healthcare ConferenceNYSE:ALCAlcon Inc
 Apresentando as notícias mais relevantes sobre:NYSE:ALC

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
FNAM11
Fundo Invest Amazonia Fi...
BOV
AGXY3
Agrogalaxy Participacoes ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios